Skip to main content
Top
Published in: BMC Cardiovascular Disorders 1/2008

Open Access 01-12-2008 | Research article

The interaction of vasoactive substances during exercise modulates platelet aggregation in hypertension and coronary artery disease

Authors: Konstantinos Petidis, Stella Douma, Michael Doumas, Ilias Basagiannis, Konstantinos Vogiatzis, Chrysanthos Zamboulis

Published in: BMC Cardiovascular Disorders | Issue 1/2008

Login to get access

Abstract

Background

Acute vigorous exercise, associated with increased release of plasma catecholamines, transiently increases the risk of primary cardiac arrest. We tested the effect of acute submaximal exercise on vasoactive substances and their combined result on platelet function.

Methods

Healthy volunteers, hypertensive patients and patients with coronary artery disease (CAD) performed a modified treadmill exercise test. We determined plasma catecholamines, thromboxane A2, prostacyclin, endothelin-1 and platelet aggregation induced by adenosine diphosphate (ADP) and collagen at rest and during exercise.

Results

Our results during exercise showed a) platelet activation (increased thromboxane B2, TXB2), b) increased prostacyclin release from endothelium and c) decreased platelet aggregation in all groups, significantly more in healthy volunteers than in patients with CAD (with hypertensives lying in between these two groups).

Conclusion

Despite the pronounced activation of Sympathetic Nervous System (SNS) and increased TXB2 levels during acute exercise platelet aggregation decreases, possibly to counterbalance the prothrombotic state. Since this effect seems to be mediated by the normal endothelium (through prostacyclin and nitric oxide), in conditions characterized by endothelial dysfunction (hypertension, CAD) reduced platelet aggregation is attenuated, thus posing such patients in increased risk for thrombotic complications.
Appendix
Available only for authorised users
Literature
1.
go back to reference Faxon DP, Fuster V, Libby P, Beckman JA, Hiatt WR, Thompson RW, Topper JN, Annex BH, Rundback JH, Fabunmi RP, Robertson RM, Loscalzo J: Atherosclerotic Vascular Disease Conference Writing Group III: Pathophysiology. Circulation. 2004, 109: 2617-2625. 10.1161/01.CIR.0000128520.37674.EF.CrossRefPubMed Faxon DP, Fuster V, Libby P, Beckman JA, Hiatt WR, Thompson RW, Topper JN, Annex BH, Rundback JH, Fabunmi RP, Robertson RM, Loscalzo J: Atherosclerotic Vascular Disease Conference Writing Group III: Pathophysiology. Circulation. 2004, 109: 2617-2625. 10.1161/01.CIR.0000128520.37674.EF.CrossRefPubMed
2.
go back to reference Ware JA, Heistad DD: Platelet-Endothelium interactions. N Engl J Med. 1993, 328: 628-635. 10.1056/NEJM199303043280907.CrossRefPubMed Ware JA, Heistad DD: Platelet-Endothelium interactions. N Engl J Med. 1993, 328: 628-635. 10.1056/NEJM199303043280907.CrossRefPubMed
3.
go back to reference Lip GY: Hypertension and the prothrombotic state. J Hum Hypertens. 2000, 14: 687-690. 10.1038/sj.jhh.1001051.CrossRefPubMed Lip GY: Hypertension and the prothrombotic state. J Hum Hypertens. 2000, 14: 687-690. 10.1038/sj.jhh.1001051.CrossRefPubMed
4.
go back to reference Kjeldsen SE, Neubig RR, Weder AB, Zweifler AJ: The hypertension-coronary heart disease dilemma: the catecholamine-blood platelet connection. J Hypertens. 1989, 7: 851-860. 10.1097/00004872-198911000-00001.CrossRefPubMed Kjeldsen SE, Neubig RR, Weder AB, Zweifler AJ: The hypertension-coronary heart disease dilemma: the catecholamine-blood platelet connection. J Hypertens. 1989, 7: 851-860. 10.1097/00004872-198911000-00001.CrossRefPubMed
5.
go back to reference Loscalzo J: Nitric oxide insufficiency, platelet activation, and arterial thrombosis. Circ Res. 2001, 88: 756-762. 10.1161/hh0801.089861.CrossRefPubMed Loscalzo J: Nitric oxide insufficiency, platelet activation, and arterial thrombosis. Circ Res. 2001, 88: 756-762. 10.1161/hh0801.089861.CrossRefPubMed
6.
go back to reference Paffenbarger RS, Hyde RT, Wing AL, Lee I-M, Jung DL, Kampert JB: The Association of Changes in Physical-Activity Level and Other Lifestyle Characteristics with Mortality among Men. N Engl J Med. 1993, 328: 538-545. 10.1056/NEJM199302253280804.CrossRefPubMed Paffenbarger RS, Hyde RT, Wing AL, Lee I-M, Jung DL, Kampert JB: The Association of Changes in Physical-Activity Level and Other Lifestyle Characteristics with Mortality among Men. N Engl J Med. 1993, 328: 538-545. 10.1056/NEJM199302253280804.CrossRefPubMed
7.
go back to reference Siscovick DS, Weiss NS, Fletcher RH, Lasky T: The incidence of primary cardiac arrest during vigorous exercise. N Engl J Med. 1984, 311: 874-877.CrossRefPubMed Siscovick DS, Weiss NS, Fletcher RH, Lasky T: The incidence of primary cardiac arrest during vigorous exercise. N Engl J Med. 1984, 311: 874-877.CrossRefPubMed
8.
go back to reference Tofler GH, Brezinski DA, Schafer AI, Czeisler CA, Rutherford JD, Willich SN, Gleason RE, Williams GH, Muller JE: Concurrent morning increase in platelet aggregability and the risk of myocardial infarction and sudden death. N Engl J Med. 1987, 316: 1514-1518.CrossRefPubMed Tofler GH, Brezinski DA, Schafer AI, Czeisler CA, Rutherford JD, Willich SN, Gleason RE, Williams GH, Muller JE: Concurrent morning increase in platelet aggregability and the risk of myocardial infarction and sudden death. N Engl J Med. 1987, 316: 1514-1518.CrossRefPubMed
9.
go back to reference Hjemdahl P, Larsson PT, Wallén NH: Effects of stress and β-blockade on platelet function. Circulation. 1991, 84 (6 Suppl): VI44-61.PubMed Hjemdahl P, Larsson PT, Wallén NH: Effects of stress and β-blockade on platelet function. Circulation. 1991, 84 (6 Suppl): VI44-61.PubMed
10.
go back to reference Kestin AS, Ellis PA, Barnard MR, Errichetti A, Rosner BA, Michelson AD: Effect of strenuous exercise on platelet activation state and reactivity. Circulation. 1993, 88: 1502-1511.CrossRefPubMed Kestin AS, Ellis PA, Barnard MR, Errichetti A, Rosner BA, Michelson AD: Effect of strenuous exercise on platelet activation state and reactivity. Circulation. 1993, 88: 1502-1511.CrossRefPubMed
11.
go back to reference Larsson PT, Wallen NH, Hjemdahl P: Norepinephrine-induced human platelet activation in vivo is only partly counteracted by aspirin. Circulation. 1994, 89: 1951-1957.CrossRefPubMed Larsson PT, Wallen NH, Hjemdahl P: Norepinephrine-induced human platelet activation in vivo is only partly counteracted by aspirin. Circulation. 1994, 89: 1951-1957.CrossRefPubMed
12.
go back to reference Goto S, Ikeda Y, Murata M, Handa M: Epinephrine Augments von Willebrand Factor-Dependent Shear-Induced Platelet Aggregation. Circulation. 1992, 86: 1859-1863.CrossRefPubMed Goto S, Ikeda Y, Murata M, Handa M: Epinephrine Augments von Willebrand Factor-Dependent Shear-Induced Platelet Aggregation. Circulation. 1992, 86: 1859-1863.CrossRefPubMed
13.
go back to reference Hjemdahl P, Chronos NA, Wilson DJ, Bouloux P, Goodall AH: Epinephrine sensitizes human platelets in vivo and in vitro as studied by fibrinogen binding and P-selectin. Arterioscler Thromb Vasc Biol. 1994, 14 (10): 77-84.CrossRef Hjemdahl P, Chronos NA, Wilson DJ, Bouloux P, Goodall AH: Epinephrine sensitizes human platelets in vivo and in vitro as studied by fibrinogen binding and P-selectin. Arterioscler Thromb Vasc Biol. 1994, 14 (10): 77-84.CrossRef
14.
go back to reference Douma S, Zamboulis Chr, Karagiannis A, Sinakos Z: The effects of Adrenaline infusion on serum thromboxane β2 and plasma β-thromboglobulin levels in hypertensives and normotensive subjects. Nouvelle Revue Francaise d'Hematologie. 1992, 34: 73-8.PubMed Douma S, Zamboulis Chr, Karagiannis A, Sinakos Z: The effects of Adrenaline infusion on serum thromboxane β2 and plasma β-thromboglobulin levels in hypertensives and normotensive subjects. Nouvelle Revue Francaise d'Hematologie. 1992, 34: 73-8.PubMed
15.
go back to reference Mores N, Martire M, Pistritto G, Volpe AR, Menini E, Folli G, Cardillo C: Platelet alpha2-adrenoreceptors and diurnal changes of platelet aggregability in hypertensive patients. J Hypertens. 1994, 12: 939-945. 10.1097/00004872-199408000-00012.CrossRefPubMed Mores N, Martire M, Pistritto G, Volpe AR, Menini E, Folli G, Cardillo C: Platelet alpha2-adrenoreceptors and diurnal changes of platelet aggregability in hypertensive patients. J Hypertens. 1994, 12: 939-945. 10.1097/00004872-199408000-00012.CrossRefPubMed
16.
go back to reference Berlin I, Crespo-Laumonnier B, Cournot A, Landault C: The alpha-2-adrenergic receptor antagonist yohimbine inhibits epinephrine-induced platelet aggregation in healthy subjects. Clin Pharmacol Ther. 1991, 49: 362-369.CrossRefPubMed Berlin I, Crespo-Laumonnier B, Cournot A, Landault C: The alpha-2-adrenergic receptor antagonist yohimbine inhibits epinephrine-induced platelet aggregation in healthy subjects. Clin Pharmacol Ther. 1991, 49: 362-369.CrossRefPubMed
17.
go back to reference Wang JS, Cheng LJ: Effect of strenuous, acute exercise on α2-adrenergic agonist-potentiated platelet activation. Arterioscler Thromb Vasc Biol. 1999, 19 (6): 1559-1565.CrossRefPubMed Wang JS, Cheng LJ: Effect of strenuous, acute exercise on α2-adrenergic agonist-potentiated platelet activation. Arterioscler Thromb Vasc Biol. 1999, 19 (6): 1559-1565.CrossRefPubMed
18.
go back to reference Lin H, Young DB: Opposing effects of plasma epinephrine and norepinephrine on coronary thrombosis in vivo. Circulation. 1995, 91: 1135-1142.CrossRefPubMed Lin H, Young DB: Opposing effects of plasma epinephrine and norepinephrine on coronary thrombosis in vivo. Circulation. 1995, 91: 1135-1142.CrossRefPubMed
19.
go back to reference Kjeldsen SE, Weder AB, Egan B, Neubig R, Zweifler AJ, Julius S: Effect of circulating epinephrine on platelet function and hematocrit. Hypertension. 1995, 25: 1096-1105.CrossRefPubMed Kjeldsen SE, Weder AB, Egan B, Neubig R, Zweifler AJ, Julius S: Effect of circulating epinephrine on platelet function and hematocrit. Hypertension. 1995, 25: 1096-1105.CrossRefPubMed
20.
go back to reference Queen LR, Xu B, Horinouchi K, Fisher I, Ferro A: β2-Adrenoceptors Activate Nitric Oxide Synthase in Human Platelets. Circulation Research. 2000, 87: 39-44.CrossRefPubMed Queen LR, Xu B, Horinouchi K, Fisher I, Ferro A: β2-Adrenoceptors Activate Nitric Oxide Synthase in Human Platelets. Circulation Research. 2000, 87: 39-44.CrossRefPubMed
21.
go back to reference Jones CJH, DeFily DV, Patterson JL, Chilian WM: Endothelium-dependent relaxation competes with α1- and α2-adrenergic constriction in the canine epicardial coronary microcirculation. Circulation. 1993, 87: 1264-1274.CrossRefPubMed Jones CJH, DeFily DV, Patterson JL, Chilian WM: Endothelium-dependent relaxation competes with α1- and α2-adrenergic constriction in the canine epicardial coronary microcirculation. Circulation. 1993, 87: 1264-1274.CrossRefPubMed
22.
go back to reference Oates JA, Fitzgerald GA, Branch RA, Jackson EK, Knapp HR, Roberts LJ: Clinical implications of prostaglandin and thromboxane A2 formation (I). N Engl J Med. 1988, 319: 689-698.CrossRefPubMed Oates JA, Fitzgerald GA, Branch RA, Jackson EK, Knapp HR, Roberts LJ: Clinical implications of prostaglandin and thromboxane A2 formation (I). N Engl J Med. 1988, 319: 689-698.CrossRefPubMed
23.
go back to reference de Graaf JC, Banga JD, Moncada S, Palmer RMJ, de Groot PG, Sixma JJ: Nitric oxide functions as an inhibitor of platelet adhesion under flow conditions. Circulation. 1992, 85: 2284-2290.CrossRefPubMed de Graaf JC, Banga JD, Moncada S, Palmer RMJ, de Groot PG, Sixma JJ: Nitric oxide functions as an inhibitor of platelet adhesion under flow conditions. Circulation. 1992, 85: 2284-2290.CrossRefPubMed
24.
go back to reference Hambrecht R, Adams V, Erbs S, Linke A, Krankel N, Shu Y, Baither Y, Gielen S, Thiele H, Gummert JF, Mohr FW, Schuler G: Regular physical activity improves endothelial function in patients with coronary artery disease by increasing phosphorylation of endothelial nitric oxide synthase. Circulation. 2003, 107: 3152-3158. 10.1161/01.CIR.0000074229.93804.5C.CrossRefPubMed Hambrecht R, Adams V, Erbs S, Linke A, Krankel N, Shu Y, Baither Y, Gielen S, Thiele H, Gummert JF, Mohr FW, Schuler G: Regular physical activity improves endothelial function in patients with coronary artery disease by increasing phosphorylation of endothelial nitric oxide synthase. Circulation. 2003, 107: 3152-3158. 10.1161/01.CIR.0000074229.93804.5C.CrossRefPubMed
25.
go back to reference Wang J-S, Jen CJ, Chen H-I: Effects of chronic exercise and deconditioning on platelet function in women. J Appl Physiol. 1997, 83: 2080-2085.PubMed Wang J-S, Jen CJ, Chen H-I: Effects of chronic exercise and deconditioning on platelet function in women. J Appl Physiol. 1997, 83: 2080-2085.PubMed
26.
go back to reference Nadar SK, Blann AD, Kamath S, Beevers DG, Gregory YH, Lip GYH: Platelet indexes in relation to target organ damage in high-risk hypertensive patients. A substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT). J Am Coll Cardiol. 2004, 44: 415-422. 10.1016/j.jacc.2004.03.067.CrossRefPubMed Nadar SK, Blann AD, Kamath S, Beevers DG, Gregory YH, Lip GYH: Platelet indexes in relation to target organ damage in high-risk hypertensive patients. A substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT). J Am Coll Cardiol. 2004, 44: 415-422. 10.1016/j.jacc.2004.03.067.CrossRefPubMed
27.
go back to reference Blann AD, Nadar S, Lip GYH: Pharmacological Modulation of Platelet Function in Hypertension. Hypertension. 2003, 42: 1-10.1161/01.HYP.0000077901.84467.E1.CrossRefPubMed Blann AD, Nadar S, Lip GYH: Pharmacological Modulation of Platelet Function in Hypertension. Hypertension. 2003, 42: 1-10.1161/01.HYP.0000077901.84467.E1.CrossRefPubMed
28.
go back to reference Minuz P, Patrignani P, Gaino S, Seta F, Capone ML, Tacconelli S, Degan M: Determinants of platelet activation in human essential hypertension. Hypertension. 2004, 43: 64-70. 10.1161/01.HYP.0000105109.44620.1B.CrossRefPubMed Minuz P, Patrignani P, Gaino S, Seta F, Capone ML, Tacconelli S, Degan M: Determinants of platelet activation in human essential hypertension. Hypertension. 2004, 43: 64-70. 10.1161/01.HYP.0000105109.44620.1B.CrossRefPubMed
29.
go back to reference Todd MK, Goldfarb AH, Boyer BT: Effect of exercise intensity on 6-keto-PGF1 alpha, TXB2 and on 6-keto-PGF1 alpha/TXB2 ratios. Thromb Res. 1992, 65: 487-493. 10.1016/0049-3848(92)90200-T.CrossRefPubMed Todd MK, Goldfarb AH, Boyer BT: Effect of exercise intensity on 6-keto-PGF1 alpha, TXB2 and on 6-keto-PGF1 alpha/TXB2 ratios. Thromb Res. 1992, 65: 487-493. 10.1016/0049-3848(92)90200-T.CrossRefPubMed
30.
go back to reference Lemne C, Vesterqvist O, Egberg N, Green K, Jogestrand T, de Faire U: Platelet activation and prostacyclin release in essential hypertension. Prostaglandins. 1992, 44 (3): 219-235. 10.1016/0090-6980(92)90015-L.CrossRefPubMed Lemne C, Vesterqvist O, Egberg N, Green K, Jogestrand T, de Faire U: Platelet activation and prostacyclin release in essential hypertension. Prostaglandins. 1992, 44 (3): 219-235. 10.1016/0090-6980(92)90015-L.CrossRefPubMed
31.
go back to reference Piret A, Niset G, Depiesse E, Wyns W, Boeynaems JM, Poortmans J, Degre S: Increased platelet aggregability and prostacyclin biosynthesis induced by intense physical exercise. Thromb Res. 1990, 57: P685-695. 10.1016/0049-3848(90)90026-9.CrossRef Piret A, Niset G, Depiesse E, Wyns W, Boeynaems JM, Poortmans J, Degre S: Increased platelet aggregability and prostacyclin biosynthesis induced by intense physical exercise. Thromb Res. 1990, 57: P685-695. 10.1016/0049-3848(90)90026-9.CrossRef
32.
go back to reference Harrison VJ, Barnes K, Turner AJ, Wood E, Corder R, Vane JR: Identification of Endothelin 1 and Big Endothelin 1 in Secretory Vesicles Isolated from Bovine Aortic Endothelial Cells. PNAS. 1995, 92: 6344-6348. 10.1073/pnas.92.14.6344.CrossRefPubMedPubMedCentral Harrison VJ, Barnes K, Turner AJ, Wood E, Corder R, Vane JR: Identification of Endothelin 1 and Big Endothelin 1 in Secretory Vesicles Isolated from Bovine Aortic Endothelial Cells. PNAS. 1995, 92: 6344-6348. 10.1073/pnas.92.14.6344.CrossRefPubMedPubMedCentral
33.
go back to reference Haynes WG, Webb DJ: Endothelin as a regulator of cardiovascular function in health and disease. J Hypertens. 1998, 16: 1081-1098. 10.1097/00004872-199816080-00001.CrossRefPubMed Haynes WG, Webb DJ: Endothelin as a regulator of cardiovascular function in health and disease. J Hypertens. 1998, 16: 1081-1098. 10.1097/00004872-199816080-00001.CrossRefPubMed
34.
go back to reference Pietraszek MH, Takada Y, Takada A: Endothelins inhibit serotonin-induced platelet aggregation via a mechanism involving protein kinase C. European journal of Pharmacology. 1992, 219: 289-293. 10.1016/0014-2999(92)90308-Q.CrossRefPubMed Pietraszek MH, Takada Y, Takada A: Endothelins inhibit serotonin-induced platelet aggregation via a mechanism involving protein kinase C. European journal of Pharmacology. 1992, 219: 289-293. 10.1016/0014-2999(92)90308-Q.CrossRefPubMed
35.
go back to reference Liras A, Catalan RE, Martinez AM: Synergistic Effect of Endothelin-1 and Serotonin in Rabbit Platelets: Effect on Tyrosine Phosphorylation. Thrombosis Research. 2000, 100: 325-331. 10.1016/S0049-3848(00)00328-5.CrossRefPubMed Liras A, Catalan RE, Martinez AM: Synergistic Effect of Endothelin-1 and Serotonin in Rabbit Platelets: Effect on Tyrosine Phosphorylation. Thrombosis Research. 2000, 100: 325-331. 10.1016/S0049-3848(00)00328-5.CrossRefPubMed
36.
go back to reference Dockrell MEC, Walker BR, Noon JP, Graham C.M, Watt GCM, Brent C, Williams BC, Webb DJ: Platelet Aggregation in Young Men with Contrasting Predisposition to High Blood Pressure. Am J Hypertens. 1999, 12: 115-119. 10.1016/S0895-7061(98)00215-5.CrossRefPubMed Dockrell MEC, Walker BR, Noon JP, Graham C.M, Watt GCM, Brent C, Williams BC, Webb DJ: Platelet Aggregation in Young Men with Contrasting Predisposition to High Blood Pressure. Am J Hypertens. 1999, 12: 115-119. 10.1016/S0895-7061(98)00215-5.CrossRefPubMed
37.
go back to reference Lee KW, Lip GYH: Effects of lifestyle on hemostasis, fibrinolysis and platelet reactivity. Arch Intern Med. 2003, 163: 2368-2392. 10.1001/archinte.163.19.2368.CrossRefPubMed Lee KW, Lip GYH: Effects of lifestyle on hemostasis, fibrinolysis and platelet reactivity. Arch Intern Med. 2003, 163: 2368-2392. 10.1001/archinte.163.19.2368.CrossRefPubMed
38.
go back to reference Meade TW, Vickers MV, Thompson SG, Stirling Y, Haines AP, Miller GJ: Epidemiological characteristics of platelet aggregability. BMJ. 1985, 290: 428-32.CrossRefPubMedPubMedCentral Meade TW, Vickers MV, Thompson SG, Stirling Y, Haines AP, Miller GJ: Epidemiological characteristics of platelet aggregability. BMJ. 1985, 290: 428-32.CrossRefPubMedPubMedCentral
Metadata
Title
The interaction of vasoactive substances during exercise modulates platelet aggregation in hypertension and coronary artery disease
Authors
Konstantinos Petidis
Stella Douma
Michael Doumas
Ilias Basagiannis
Konstantinos Vogiatzis
Chrysanthos Zamboulis
Publication date
01-12-2008
Publisher
BioMed Central
Published in
BMC Cardiovascular Disorders / Issue 1/2008
Electronic ISSN: 1471-2261
DOI
https://doi.org/10.1186/1471-2261-8-11

Other articles of this Issue 1/2008

BMC Cardiovascular Disorders 1/2008 Go to the issue